Ashok Rattan*

Independent Board Member and Strategic Advisor, Diagnostic Laboratory Gover- nance | Molecular and Next-Gen IVD Strategy, South Delhi, Delhi, India

*Corresponding Author: Ashok Rattan, Independent Board Member and Strategic Advisor, Diagnostic Laboratory Governance | Molecular and Next-Gen IVD Strategy, South Delhi, Delhi, India.

Received: May 18, 2026; Published: July 08, 2026

Abstract

The accurate differentiation of bacterial from viral infections at the point of care remains one of the most clinically consequen- tial and diagnostically challenging problems in medicine. Inappropriate antibiotic prescribing, overwhelmingly driven by diagnostic uncertainty, fuels antimicrobial resistance, increases treatment costs, and exposes patients to avoidable harm. The complete blood count (CBC) and C-reactive protein (CRP), obtained routinely in almost every clinical setting worldwide, encode a rich pattern of host-response signals that differ fundamentally between bacterial and viral infections. This review synthesises the biological basis of these differences, evaluates the discriminatory performance of individual CBC parameters and CRP, and examines landmark machine learning (ML) evidence including a 44,120-case XGBoost model achieving an AUC of 0.905 [1] that confirms the superior power of integrating CBC with CRP over CRP alone, particularly in the diagnostically ambiguous 10-40 mg/L CRP grey zone. We further re- view recently FDA-cleared point-of-care tests, including the FebriDx MxA/CRP lateral flow assay and the MeMed BV TRAIL/IP-10/ CRP host-response platform, appraising their performance and their practical and economic feasibility in the Indian context. We conclude that an intelligently implemented CBC+CRP approach, supported by an offline computational app running on a smartphone or computer, offers India a scientifically validated, diagnostically powerful, and economically accessible solution, one that is highly synergistic with existing laboratory infrastructure across public and private healthcare settings.

Keywords: Complete Blood Count; C-Reactive Protein; Neutrophil-to-Lymphocyte Ratio; Bacterial Infection; Viral Infection; Machine Learning; FebriDx; MxA; Antimicrobial Stewardship; Point-of-Care Testing; India

References

1. Guncar G., et al. “A machine learning model to differentiate bacterial from viral infection using routine blood parameters and CRP”. Heliyon 10 (2024): e29372.
2. Allan-Blitz LT and Klausner JD. “A Rapid Test to Differentiate Viral From Bacterial Infections: Searching for the Holy Grail”. Clinical Infectious Disease (2025).
3. Shapiro NI., et al. “Diagnostic accuracy of a bacterial and viral biomarker point-of-care test in the outpatient setting”. JAMA Network Open 5 (2022): e2234588.
4. Wilcox CR., et al. “Use of the FebriDx host-response point-of-care test may reduce antibiotic use for respiratory tract infections in primary care”. Journal of Antimicrobe Chemotherapy 79 (2024): 1441-1449.
5. Tong-Minh K., et al. “Performance of the FebriDx rapid point-of-care test for differentiating bacterial and viral respiratory tract infections”. Journal of Clinical Medicine 13 (2023): 163.
6. Oved K., et al. “A novel host-proteome signature for distinguishing between acute bacterial and viral infections”. PLoS ONE 10 (2015): e0120012.
7. De Jager CPC., et al. “The neutrophil-to-lymphocyte count ratio in community-acquired pneumonia”. PLoS ONE 7 (2012): e46561.
8. Cataudella E., et al. “Neutrophil-to-lymphocyte ratio: an emerging marker predicting prognosis in elderly adults with community-acquired pneumonia”. Journal of the American Geriatrics Society 65 (2017): 1796-1801.
9. Kamat IS., et al. “Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis”. Clinical Infectious Disease 70 (2020): 538-542.
10. Laxminarayan R., et al. “Access to effective antimicrobials: a worldwide challenge”. Lancet 387 (2016): 168-175.
11. Dick K and Schneider J. “Economic evaluation of FebriDx: a novel rapid, point-of-care test for differentiation of viral versus bacterial acute respiratory infection in the United States”. Journal of Health Economics and Outcomes Research 8 (2021): 56-62.
12. ICMR AMR Surveillance Network. “Annual Report on Antimicrobial Resistance in India”. Indian Council of Medical Research (2023).
13. Frohlich F., et al. “Expression of TRAIL, IP-10, and CRP in children with suspected COVID-19”. Infection 51 (2023): 1349-56.
14. Lien HS., et al. “Bacteremia detection from complete blood count and differential leukocyte count with machine learning”. BMC Infectious Disease 22 (2022): 287.
15. Ramgopal S., et al. “Machine learning to predict serious bacterial infections in young febrile infants”. Paediatrics 146 (2020): e20194096.

Citation

Citation: Ashok Rattan. “Complete Blood Count with C-Reactive Protein for Rapid Differentiation of Bacterial from Viral Infections: Clinical Evidence, Ma- chine Learning Validation, FDA-Approved Diagnostics, and Implications for Point-of-Care Testing in India". Acta Scientific Microbiology 9.7 (2026): 44-55.

Copyright

Copyright: © 2026 Ashok Rattan. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.